Suchergebnisse - "Ghia, Paolo"

PubPharm (453)

1

Diagnosis and Tracking of SARS-CoV-2 Infection By T-Cell Receptor Sequencing

enthalten in: bioRxiv.org | 2024

von Gittelman, R. | Lavezzo, E. | Snyder, T. | +25

2

Acalabrutinib-based regimens in frontline or relapsed/refractory higher-risk CLL : Pooled analysis of 5 clinical trials

enthalten in: Blood advances | 2024

von Davids, M. | Sharman, J. | Ghia, P. | +9

3

Ibrutinib in CLL : benefit for all?

enthalten in: Blood | 2024

von Cuneo, A. | Ghia, P.

4

Analysis of ventricular arrhythmias and sudden death from prospective, randomized clinical trials of acalabrutinib

enthalten in: British journal of haematology | 2024

von Sharman, J. | Ghia, P. | Miranda, P. | +4

5

IκBε deficiency accelerates disease development in chronic lymphocytic leukemia

enthalten in: Leukemia | 2024

von Bordini, J. | Lenzi, C. | Frenquelli, M. | +24

6

Disrupting pro-survival and inflammatory pathways with dimethyl fumarate sensitizes chronic lymphocytic leukemia to cell death

enthalten in: Cell death & disease | 2024

von Mantione, M. | Meloni, M. | Sana, I. | +8

7

COMPOSITIONS AND METHODS FOR CHIMERIC ANTIGEN RECEPTORS SPECIFIC TO B CELL RECEPTORS

enthalten in: Europäisches Patentamt | 2024

von RUELLA MARCO | SCHUSTER STEPHEN | STAMATOPOULOS KOSTAS | +3

8

Updates of the ERIC recommendations on how to report the results from immunoglobulin heavy variable gene analysis in chronic lymphocytic leukemia

enthalten in: Leukemia | 2024

von Chatzikonstantinou, T. | Agathangelidis, A. | Chatzidimitriou, A. | +11

9

Characterization of zanubrutinib safety and tolerability profile and comparison with ibrutinib safety profile in patients with B-cell malignancies : post-hoc analysis of a large clinical trial safety database

enthalten in: Haematologica | 2024

von Brown, J. | Ghia, P. | Jurczak, W. | +14

10

Proliferative History Is a Novel Driver of Clinical Outcome in Splenic Marginal Zone Lymphoma

enthalten in: bioRxiv.org | 2024

von Parker, H. | Mirandari, A. | Oquendo, C. | +42

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[46]